A systematic review of Vancouver B2 and B3 periprosthetic femoral fractures by Khan, T. et al.
VOL. 99-B, No. 4, APRIL 2017 17
 HIP
A systematic review of Vancouver B2 and B3 
periprosthetic femoral fractures
T. Khan,
D. Grindlay,
B. J. Ollivere,
B. E. Scammell,
A. R. J. Manktelow,
R. G. Pearson
From the University 
of Nottingham, 
Nottingham, United 
Kingdom
 T. Khan, MRCS(Eng), 
National Joint Registry/Royal 
College of Surgeons of England 
Research Fellow and Specialty 
Registrar in Trauma and 
Orthopaedic Surgery, 
Department of Academic 
Orthopaedics, Trauma and 
Sports Medicine,
 D. Grindlay, PhD, 
Information Specialist, 
Department of Academic 
Orthopaedics, Trauma and 
Sports Medicine,
 B. J. Ollivere, MD, 
FRCS(T&O), Associate 
Professor of Trauma Surgery 
and Consultant Trauma and 
Orthopaedic Surgeon, 
Department of Academic 
Orthopaedics, Trauma and 
Sports Medicine,
 B. E. Scammell, MD, 
FRCS(T&O), Professor of 
Trauma & Orthopaedic Surgery
 R. G. Pearson, PhD, Senior 
Research Fellow, Department of 
Academic Orthopaedics, 
Trauma and Sports Medicine,
University of Nottingham, 
Nottingham NG7 2NR, UK.
 A. R. J. Manktelow, BSc, 
MBBS, FRCS(Ed), FRCS(Orth), 
Consultant Trauma and 
Orthopaedic Surgeon, 
Department of Academic 
Orthopaedics, Trauma and 
Sports Medicine,
Nottingham University 
Hospitals NHS Trust, 
Nottingham, UK.
Correspondence should be sent 
to T. Khan; email: 
tanvirkhan@doctors.org.uk
©2017 Khan et al
doi:10.1302/0301-620X.99B4. 
BJJ-2016-1311.R1 $2.00
Bone Joint J 
2017;(4 Supple B):17–25. 
Aims
The aim of this study was to investigate the outcomes of Vancouver type B2 and B3 
fractures by performing a systematic review of the methods of surgical treatment which 
have been reported.
Materials and Methods
A systematic search was performed in Ovid MEDLINE, Embase and the Cochrane Central 
Register of Controlled Trials. For inclusion, studies required a minimum of ten patients with 
a Vancouver type B2 and/or ten patients with a Vancouver type B3 fracture, a minimum 
mean follow-up of two years and outcomes which were matched to the type of fracture. 
Studies were also required to report the rate of re-operation as an outcome measure. The 
protocol was registered in the PROSPERO database. 
Results
A total of 22 studies were included based on the eligibility criteria, including 343 B2 fractures 
and 167 B3 fractures. The mean follow-up ranged from 32 months to 74 months. 
Of 343 Vancouver B2 fractures, the treatment in 298 (86.8%) involved revision arthroplasty 
and 45 (12.6%) were treated with internal fixation alone. A total of 37 patients (12.4%) 
treated with revision arthroplasty and six (13.3%) treated by internal fixation only 
underwent further re-operation. 
Of 167 Vancouver B3 fractures, the treatment in 160 (95.8%) involved revision arthroplasty 
and eight (4.8%) were treated with internal fixation without revision. A total of 23 patients 
(14.4%) treated with revision arthroplasty and two (28.6%) treated only with internal 
fixation required re-operation.
Conclusion
A significant proportion, particularly of B2 fractures, were treated without revision of the 
stem. These were associated with a higher rate of re-operation. The treatment of B3 
fractures without revision of the stem resulted in a high rate of re-operation. This 
demonstrates the importance of careful evaluation and accurate characterisation of the 
fracture at the time of presentation to ensure the correct management. There is a need for 
improvement in the reporting of data in case series recording the outcome of the surgical 
treatment of periprosthetic fractures. We have suggested a minimum dataset to improve 
the quality of data in studies dealing with these fractures.
Cite this article: Bone Joint J 2017;99-B(4 Supple B):17–25.
As the number of total hip arthroplasties
(THA) being performed worldwide continues
to increase,1,2 so does the incidence of
periprosthetic femoral fracture. Based on the
predictive modelling of National Joint Registry
(NJR) data,2 it has been projected that the
numbers of primary and revision THAs in Eng-
land and Wales will reach 186 893 and 137
056, respectively, by 2030.2 A higher risk of
periprosthetic femoral fracture has been
shown in revision THA3 but also following
uncemented femoral fixation,4 which is
increasingly being used.1,2,5 The incidence of
periprosthetic femoral fractures will therefore
continue to rise. The Swedish National Hip
Arthroplasty Register,6 which contains data
from 1979 onwards, shows periprosthetic
fracture as the second most common reason
for revision beyond four years after primary
arthroplasty.7
The management algorithm surrounding the
treatment of periprosthetic femoral fractures is
complex. Various factors determine the correct
form of treatment. The major influences are
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the location of the fracture relative to the implant, the state
of fixation of the implant and the influence of the quality of
the surrounding bone. These three variables are identified
in the Vancouver classification and form the basis of the
established algorithm of management.8 B2 fractures may,
however, be difficult to identify when implant loosening is
not obvious, and the determination of B3 status can be sub-
jective. In this study, one of the objectives was to demon-
strate supportive evidence for the importance of attributing
an accurate Vancouver classification to the fracture.
A number of studies have indicated a poorer outcome
and higher mortality after revision for periprosthetic frac-
ture compared with other indications for revision.9-11 Drew
et al12 calculated the combined risk of either death or re-
operation in the first year after a periprosthetic femoral
fracture to be 24%. Furthermore, the costs associated with
the treatment of these fractures are significant.13,14 In
todays’ challenging healthcare environment, only a success-
ful clinical outcome will provide cost effective manage-
ment. 
Many of these fractures are Vancouver types B2 or
B3.8,15 Data from the Swedish National Hip Arthroplasty
Register, showed that 555 of 1049 (53%) periprosthetic
femoral fractures were type B2 and 43 (4.1%) were type
B3.16 Due to the presence of a loose stem with either good
(Type B2) or poor bone stock (Type B3), revision surgery is
generally recommended. 
Joint registries can provide an analysis of revision surg-
ery for periprosthetic femoral fractures, but the breadth of
data collected is limited. Much of this is related to the dif-
ficulties of collecting appropriate data at the time of an
emergency admission for fracture. Similarly, registry data
will not identify the entire cohort, specifically will often not
identify those treated with fixation alone. With the excep-
tion of publications based on the Swedish registry,16,17 most
other reported registry studies do not describe details of the
classification of the fracture and the technique of fixation
used at revision.18-21 
The results from observational studies may provide
detailed information which can be used collectively to
assess the outcome of different forms of treatment for type
B2 and B3 fractures. Although systematic reviews have
assessed the outcomes of B122,23 and C22 fractures, there
are no previous formal systematic reviews assessing the out-
comes or comparative outcomes of B2 and B3 fractures. 
The primary aim of this study was to perform a system-
atic review of the methods of surgical treatment and out-
comes of Vancouver B2 and B3 fractures. The secondary
aim was to compare the outcomes in fractures treated with
revision of the stem versus those treated with internal fixa-
tion without revision of the stem. We hypothesised that the
appropriate classification of periprosthetic fractures is crit-
ical to avoiding unnecessary further surgery and ensuring a
cost effective and successful outcome. 
Records identified through database searching
(n = 1743 (Medline) + 2118 (Embase)) 
Additional records identified through 
other sources (n = 2)
Records after duplicates removed (n = 3664)
Records screened
(n = 3664)
Full-text articles assessed for
eligibility (n = 115)
Records excluded
(n = 3452)
Full-text articles excluded 
(n = 93)
Studies included in quantitative
synthesis (n = 22)
Fig. 1
Prepared Reporting Items for Systematic Reviews and Meta-Analyses flowchart.
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Materials and Methods
We followed the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) checklist for sys-
tematic reviews.24 The review was registered on PROS-
PERO,25 an international prospective register of systematic
reviews.
A comprehensive electronic search of Ovid MEDLINE,
Embase, and the Cochrane Central Register of Controlled
Trials and Database of Systematic Reviews26 from the ear-
liest available year of indexing until August 2016 was con-
ducted. As an example, the key terms used in the Ovid
MEDLINE search are shown in supplementary material.
The electronic search was supplemented with a manual
search of the reference lists of all retrieved review articles
for any other relevant citations. Abstracts of all citations
were screened and full texts of articles were obtained to
decide on inclusion of relevant studies. The attrition flow-
chart is shown in Figure 1. 
Observational studies reporting the outcomes of surgical
treatment of periprosthetic femoral fractures after THA,
were included if: periprosthetic femoral fractures were clas-
sified according to the Vancouver system,15 they included at
least ten patients with a type B2 fracture, and/or ten
patients with a type B3 fracture. A minimum of two years
mean follow-up was required and studies had to report re-
operation (including revision arthroplasty) as an outcome
measure.
Studies were excluded if the fractures were not classified
according to the Vancouver system, or if the methods of
treatment and outcomes were not reported separately
according to the classification of the fractures.
Two authors (TK, RGP) independently extracted data
relating to the design of the study, the country of conduct,
the period of study, case selection, the assessment of out-
come and the characteristics of the patients. In cases of dis-
agreement on the data which were extracted, a third author
(BES) independently extracted the data. Quality assessment
was performed independently by two authors using the val-
idated tool specifically designed by Guo et al27 to assess the
quality of case series, and a minimum dataset was designed
to improve data reporting specific to periprosthetic femoral
fractures. 
Statistical analysis. Extracted data were entered onto Rev-
Man Version 5.3 (Cochrane, London, United Kingdom).
Treatment was categorised by the type of fracture (Vancouver
B2 or B3) and the type of treatment (revision with or with-
out open reduction and internal fixation (ORIF), ORIF
alone). The details of the component used at revision were
also recorded. The demographics of the further operations
were reported according to the type of fracture and treat-
ment. Risk Ratios (with 95% confidence intervals (CIs)) for
re-operation were calculated using the Mantel-Haenszel
random effects model28 to make comparisons between the
types of fracture and treatment. Data were represented as
Forest plots and two-tailed z tests were used with a level of
significance of 5%. Studies which reported treating both
types of fracture, or similarly used both revision with or
without ORIF and ORIF alone, could be included when
calculating Risk Ratios.
Results
A total of 22 studies fulfilled the inclusion criteria and were
included in the review. All were case series.29-50 Two
involved the same patients;32,50 data were extracted from
both separately and then combined for analysis.
A total of 510 Vancouver B2 or B3 fractures treated
between 1984 and 2012 were included for analysis. The
mean follow-up ranged between 32 months and 74 months. 
B2 fractures. A total of 343 B2 fractures were reported in
14 case series (see supplementary material). Information
about the gender was available for 125 patients (64
women: 61 men). Treatment involved revision of the stem
with or without internal fixation in 298 patients (87.6%).
A total of 45 were treated with fixation without revision of
the stem. For those treated with revision THA, cemented
stems were used in 82 (27.6%) and uncemented stems in
153 patients (51.3%). The type of stem was not specified in
63 operations (21.1%). 
A total of 43 patients (12.8%) required re-operation fol-
lowing treatment. A total of 37 patients (12.4%) who were
treated with revision of the stem with or without internal
fixation required re-operation and six (13.3%) who were
treated with internal fixation alone required re-operation.
Table I shows the re-operations by the type of fracture. 
Four studies38,39,45,49 reported the results of treating
Vancouver B2 fractures with either revision of the stem
with or without ORIF or with ORIF alone. The calculated
Risk Ratio of re-operation was 1.74 (95% CI 0.61 to
4.97, p = 0.30) in favour of revision with or without ORIF
(Fig. 2). 
Table I. Total numbers and re-operations of Vancouver B2 and B3 fractures by the type of fracture
Fracture type
Revision with or without ORIF ORIF without revision Total
Cemented Uncemented Unspecified
Total Type B2 fractures 82 153 63 45 343
Re-operations Type B2 fractures, n (%) 11 (13.4) 19 (12.4) 7 (11.1) 6 (13.3) 43 (12.5)
Total Type B3 fractures 49 90 21 7 167
Re-operations Type B3 fractures, n (%) 8 (16.3) 12 (13.3) 3 (14.3) 2 (28.6) 25 (15.0)
ORIF, open reduction and internal fixation
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Table II summarises the indications for re-operation by
the type of fracture. 
B3 fractures. There were 167 Vancouver B3 fractures in the
studies which were included (see supplementary material).
Information about the gender was available for 99 patients
(59 women, 40 men). In 160 cases (95.2%) treatment
involved revision of the stem with or without internal fixa-
tion. A total of eight patients (4.8%) were treated with
internal fixation alone. Of the 160 patients who underwent
revision THA, 90 (53.9%) involved uncemented stems, 28
(16.8) involved a cemented stem and 21 (12.6%) were
treated with a cemented stem. Revision prostheses were not
specified for 21 patients (12.6%). Table III shows the stem
designs which were used for revision in patients with both
Vancouver B2 and B3 fractures.
There were a total of 25 re-operations (15.0%) (Table I),
23 (14.4%) in patients who were treated with revision of
the stem with or without ORIF, including two who had fur-
ther surgery for a wound infection in B3 fractures treated
with a cemented stem. There were two re-operations
(28.6%) for patients treated with ORIF alone, one for a
further periprosthetic fracture and one for aseptic loosen-
ing of the stem. In two studies,42,46 the results of those
treated with both revision of the stem with or without
ORIF or ORIF alone were reported. The Risk Ratio based
on these two studies was 1.38 (95% CI 0.38 to 5.01, p =
0.63) in favour of revision of the stem with or without
ORIF (Fig. 3).
B2 versus B3 fractures. Four studies33,40,42,43 reported the
outcome of sufficient numbers (> 10) of both B2 and B3
Study or subgroup Events Total Events Total Weight (%) M-H, Fixed 95% CI M-H, Fixed, 95% CI
ORIF alone  Revision with or without ORIF Risk Ratio Risk Ratio
Inngul 201538 2 9 1 16 17.3 3.56 (0.37 to 33.98)
Lunebourg 201539 2 16 0 7 16.3 2.35 (0.13 to 43.53)
Solomon 201545 0 12 0 9  Not estimable
Zuurmond 201049 2 6 6 20 66.4 1.11 (0.30 to 4.14)
Total (95% CI)  43  52 100.0 1.74 (0.61 to 4.97)
Total events 6  7 
Heterogeneity: chi-squared =  0.87 , df = 2 (p = 0.65); 12 = 0%
Test for overall effect: Z = 1.03 (p = 0.30) 0.01 0.1 1 10 100
Favours ORIF alone Favours revision with or without ORIF
Fig. 2
Forest plot comparing the risk of re-operation for Vancouver B2 fractures treated with revision arthroplasty with or without open reduction and
internal fixation (ORIF) versus ORIF alone (M-H, Mantel-Haenszel method; CI, confidence intervals; df, degrees of freedom).
Table II. Indications for re-operation by type of fracture
Indication for re-operation B2 fractures B3 fractures
Refracture 9 2
Infection 3 3
Subsidence 6 3
Stem loosening (aseptic) 4 1
Nonunion 4 0
Dislocation 4 2
Wound infection/superficial haematoma 4 3
Implant breakage 1 1
Not specified 8 10
Total 43 25
Table III. Revision femoral stem designs used in the treatment of B2 and B3 fractures by the design of the implant
Stem design Type B2 fractures Type B3 fractures Total
Tapered, collarless polished (cemented) 24 3 27
Tapered, polished, collared (cemented) 7 0 7
Non-tapered, collared, rough finish (cemented) 23 0 23
Matte finish (cemented) 0 25 25
Tapered fluted (uncemented) 114 58 172
Distal locking (uncemented) 15 24 39
Proximal femoral replacement (cemented) 0 21 21
Unspecified cemented 28 0 28
Unspecified uncemented 46 8 54
Unspecified 41 21 62
Total 298 160 458
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fractures for a total of 180 periprosthetic fractures. The
Risk Ratio of re-operation regardless of the form of treat-
ment was 0.49 (95% CI 0.24 to 0.99, p = 0.31) in favour of
B2 fractures (Fig. 4). The Risk Ratio when excluding
patients treated with ORIF alone was 0.52 (95% CI 0.28 to
0.98, p = 0.23) in favour of B2 fractures.
Uncemented tapered fluted stems. Uncemented tapered fluted
stems were used for revision in 114 B2 fractures (33.2%) and
58 B3 fractures (34.7%). The overall percentage rate of re-
operation was 14/114 for B2 (12.3%) and 9/58 for B3 frac-
tures (15.5%). The indications for re-operation included re-
fracture (three), dislocation (three), aseptic loosening (three),
wound complications (three) and stem breakage (one). Stem
subsidence was reported in 9/172 patients (5.2%), although
only three (1.7%) of these required revision. The indication
for re-operation was not specified for seven patients. 
Quality assessment. The mean quality score was 11.5/18
(standard deviation 2.39). Only two studies34,49 reported
detailed individual case-by-case data including demo-
graphic details, diagnosis, treatment and outcomes, both
adopting a table format with a row per patient. Only five
studies35,40,41,45,47 had a mean follow-up of more than five
years. A total of 14 studies29-33,37,39-46 included either the
names of the specific prostheses or details of the design of
the stem which was used for revision. No study reported
data to allow analysis of survival. 
Discussion
This systematic review shows that as per consensus, most
Vancouver B2 and B3 fractures which are reported in the
literature are treated with revision THA with or without
internal fixation. However, for B2 fractures particularly, a
significant proportion (13.1% in this review) were treated
with internal fixation alone. This might reflect difficulties
in determining whether or not the stem was loose pre-
operatively from the available imaging. However, this
determination is important. Often the differentiation
between a Vancouver B1and B2 fracture is straightforward.
However, there are fractures, initially felt to be around
well- fixed stems, in which only a careful review of previous
radiographs or a thorough history identifying pre-existing
thigh pain, will raise the suspicion of associated loosening
of the stem. Similarly, there are specific patterns and loca-
tions of fractures, such as a relatively transverse fracture
through an area of lysis below an apparently well-fixed
stem, that should alert the surgeon to the likelihood that the
stem is failing and should be revised. We found that for
both types of fracture, treatment with internal fixation
alone was associated with a higher percentage of re-opera-
tions, but the difference in relative risk did not reach
statistical significance. Almost a third of B3 fractures
treated with internal fixation alone required re-operation.
This trend is supported by national data from the Swedish
Study or subgroup Events Total Events Total Weight (%) M-H, Fixed 95% CI M-H, Fixed, 95% CI
ORIF alone  Revision with or without ORIF Risk Ratio Risk Ratio
Montalti 201342 2 4 2 12 37.5 3.00 (0.61 to 14.86)
Spina 201446 0 3 2 7 62.5 0.40 (0.02 to 6.51)
Total (95% CI)  7  19 100.0 1.38 (0.38 to 5.01)
Total events 2  4 
Heterogeneity: chi-squared =  0.67, df = 1 (p = 0.20); 12 = 40%
Test for overall effect: Z = 0.48 (p = 0.63) 
0.01 0.1 1 10 100
Favours ORIF alone Favours revision with or without ORIF
Fig. 3
Forest plot comparing the risk of re-operation for Vancouver B3 fractures treated with revision arthroplasty with or without open reduction and
internal fixation (ORIF)versus ORIF alone (M-H, Mantel-Haenszel method; CI, confidence intervals; df, degrees of freedom).42,46
Study or subgroup Events Total Events Total Weight (%) M-H, Fixed 95% CI M-H, Random, 95% CI
Vancouver B2 Vancouver B3 Risk Ratio Risk Ratio
Fink 201432 0 22 0 10  Not estimable
Füchtmeier 201533 7 52 4 11 35.3 0.37 (0.13 to 1.05)
Marx 201240 2 15 1 14 9.0 1.87 (0.19 to 18.38)
Montalti 201342 3 13 4 16 24.6 0.92 (0.25 to 3.41)
Mukundan 201043 4 42 6 17 31.0 0.27 (0.09 to 0.84)
Total (95% CI)  144  68 100.0 0.49 (0.24 to 0.99)
Total events 16  15 
Heterogeneity: Tau2 =  0.09 , chi-squared = 3.59, df = 3 (p = 0.31); 12 = 16%
Test for overall effect: Z = 1.99 (p = 0.05) 0.001 0.1 1 10 1000
Favours B1  Favours B3
Fig. 4
Forest plot comparing the risk of re-operation for Vancouver B2 and B3 fractures (M-H, Mantel-Haenszel method; CI, confidence intervals; df,
degrees of freedom).
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National Hip Arthroplasty Register,17 which indicates a
higher percentage of re-operations for B2 fractures treated
with ORIF without revision of the stem (32%), than with
those treated with revision alone (10%) or revision com-
bined with internal fixation (23%). The overall proportion
of patients undergoing a re-operation was higher than
reported in this review which may be a reflection of the
longer follow-up of registry data as opposed to published
observational series. Another possible explanation is that
there is bias in the selection of patients which surgeons/cen-
tres treat with internal fixation alone, which may be related
to the fitness of the patients for a longer more physiologi-
cally demanding revision procedure, non-ambulatory
patients, or in those with a limited life expectancy. Some
authors have also reported good results at five-year follow-
up of treating selected B2 fractures around polished,
tapered, collarless stems in which anatomical reduction can
be achieved, with internal fixation alone.45 The informa-
tion available for this systematic review limits our ability to
address the question of which, if any, patients sustaining
Vancouver B2 or B3 fractures, would be suitable for treat-
ment with internal fixation alone. 
The analysis of included studies with sufficient data avail-
able for comparison, indicates a higher relative risk of re-
operation for B3 fractures compared with B2 fractures, even
when comparing those treated with revision of the stem with
or without fixation. Anecdotally, this has been appreciated
by surgeons experienced in the management of these frac-
tures, but there is little previous information, to quantify this
difference into risk of failure. It is important to remember
that compromise in the surrounding bone stock, that deter-
mines the differentiation of B2 and B3 fractures, is poten-
tially representative of other factors which may contribute to
a higher risk of failure, such as multiple previous operations
on the hip, previous infection or fracture, severe lysis or
osteopenia and other comorbidities, which have not been
accounted for as confounders in this analysis.
Uncemented stems were found to be more commonly
used for the management of both B2 and B3 fractures. A
significant proportion of these were tapered fluted titanium
stems with the non-modular Wagner SL stem (Zimmer
Biomet, Warsaw, Indiana) being used in almost a quarter of
all patients requiring revision of the stem. Tapered fluted
titanium stems provide reliable and versatile distal diaphy-
seal fixation, which overcomes concerns about proximal
stress shielding and the difficulties associated with
advanced proximal bone loss.51 These systems facilitate an
accurate restoration of biomechanics of the hip with
options to re-establish length and version independently,
with modular proximal components. Good results have
been reported after femoral revision for aseptic loosen-
ing.52-57 Encouraging results with these technologies have
also been reported in the management of periprosthetic
fractures.51,58-60 However, in many studies, the results are
reported as part of larger observational cohorts, with their
use in B2 and B3 fractures as only one of a number of other
indications for femoral revision. This is likely to have been
under-reported in our review as the papers did not satisfy
our inclusion criteria. 
In this systematic review, the percentage of patients
requiring re-operation using tapered fluted stems for both
B2 (12.3%) and B3 (16.7%) fractures was comparable with
those in the Swedish National Hip Arthroplasty register for
the rate of re-operation for B2 and B3 fractures treated with
revision of the stem with or without ORIF, which were
18.5% and 15.5% respectively.17 One of the complications
of these stems is subsidence of the stem. This can be a par-
ticular concern in the presence of poor bone quality. The
rates and magnitude of subsidence differ in different sys-
tems. While significant rates of subsidence have been
reported with the 2° taper angle of the Wagner SL stem,61,62
more aggressive angles of taper available in some systems
have shown lower rates of subsidence.63 The overall pro-
portion of subsidence in the stems used for Vancouver B2
and B3 fractures appears relatively low in this review. Most
studies had a follow-up of less than five years and it is likely
that significant subsidence would have occurred before that
time. It is also important to appreciate that there was vari-
ation in the threshold for what could be deemed ‘clinically
significant’ subsidence. 
This review has limitations. There is a lack of large pro-
spective studies in this field of study. Hence, the studies
which were included were all retrospective case series. A
total of 115 studies were assessed for inclusion based on the
full-text, of which only 22 were finally included. Many
were excluded either due to small numbers of periprosthetic
fractures or a lack of matched outcomes by classification of
the type of fracture. Only two studies reported individual
case-by-case details.34,49 Specifics such as the details of the
original implant, whether the fracture occurred after pri-
mary or revision THA, the strategies used for fixation and
the details of the implants for each patient would have
allowed a more detailed analysis. Furthermore, the time to
re-operation or death was not reported in any studies, and
comparative analysis of survival was not possible. 
Similar to the data from the Swedish National Hip
Arthroplasty Register, Cook et al64 reported 52% B2 and
10% B3 fractures in their study of periprosthetic fractures
following 6458 primary THAs. Recent results from the
Mayo clinic4 described 557 periprosthetic femoral fractures
from their institutional registry of 32 644 primary THAs,
of which 24.5% were B2 and 9.2% were B3. As the inci-
dence of Vancouver B2 and B3 femoral fractures continues
to rise so will the requirement for complex reconstructive
surgery with high morbidity and resulting high costs in
financial and clinical resources. 
It is important to appreciate that a significant number of
Vancouver B2 fractures may be misclassified as B1 and
treated with internal fixation without revision of the stem.
These would not have been captured in this study. There-
fore, the true re-operation rate for B2 fractures is likely to
be higher than we have recorded.
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The Vancouver classification has good intra- and inter-
observer reliability15,65-67 and is a useful tool in guiding
decision-making. It can, however, be difficult to classify
some fractures accurately. Previous authors have suggested
algorithms based on various strategies for treatment which
are available and which often depend on the design of the
existing femoral stem, the location of the fracture and its
precise configuration.68 This systematic review highlights
both the variability in the treatment of B2 and B3 fractures,
but also the significance of choosing the correct manage-
ment strategy to avoid an increased risk of re-operation. We
also found that although there are established guidelines for
the principles of management, there is a shortage of high
quality reporting of outcomes. Comparison of such studies
would allow refinement in an algorithmic approach to
management. 
Currently, the National Joint Registry, the largest arthro-
plasty register in the world, records all primary THAs per-
formed in England and Wales with matched revision
procedures by indication. However, as a large population-
based database, the breadth of data on each specific indica-
tion for revision is limited. For periprosthetic fractures,
only those undergoing revision arthroplasty are entered.
Therefore, those treated by internal fixation alone,
although a relatively small number in the case of B2 and B3
fractures, are not recorded. The classification of these frac-
tures and the details of any use of additional forms of inter-
nal fixation are also not recorded. There is therefore a
necessary reliance on detailed observational studies to
bridge this gap in information. There are reporting recom-
mendations for case series in colorectal,69 and more
recently plastic surgery.70 On this basis, we have designed a
suggested minimum dataset to aid reporting of case series
describing the outcome of periprosthetic fractures
(Table IV).
In conclusion, this study is the only systematic review of
Vancouver B2 and B3 femoral fractures. A proportion of
both types of fracture are treated by internal fixation alone
and have a higher rate of re-operation. Despite a large num-
ber of case series recording the treatment of B2 and B3 frac-
tures, the breadth and detail of data limited the quantitative
comparisons of specific forms of treatment. We have sug-
gested a minimum dataset to be used for case series describ-
ing the management of these fractures. 
Take home message:
- Vancouver B2 & B3 fractures treated with internal fixation are
associated with poorer outcomes.
- Improved reporting of periprosthetic fracture case series will allow bet-
ter evaluation of treatment modalities in specific patient groups, as well
as to allow robust analysis of implants used for revision arthroplasty.
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